Nature CommunicationsTirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetesChih-Lang LinKuan-Chou LinJung-Min YuChia-Lun ChangYu-Yi LinChih-Yuan FangWan-Ming ChenSzu-Yuan Wu2026-08-22Full textDOI https://doi.org/10.1038/s41467-026-77047-5